Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Antti Luiro

Head of Nordic ER Development, Analyst

Antti Luiro portrait

Coverage

LeadDeskNightingale HealthAiforia TechnologiesQt Group

Latest content

ShowingAll content types

Nightingale: Growth boost from proteomics

Research 08.10.2026, 09.01 by Antti Siltanen, Antti Luiro
Nightingale Health

Nightingale secures a major 5.8 MEUR project with the Michael J. Fox Foundation

Analyst Comment 02.10.2026, 09.30 by Antti Luiro
Nightingale Health

Nightingale H2'26: The mission is clear – deals, deals, deals!

Research 17.09.2026, 09.52 by Antti Siltanen, Antti Luiro
Nightingale Health

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Aiforia H1'26: Still a long way to go before reaching profitability

Research 31.08.2026, 13.26 by Antti Siltanen, Antti Luiro
Aiforia Technologies

LeadDesk Q2'26: Vi sætter opkaldet på hold i et stykke tid

Research 17.08.2026, 08.28 by Frans-Mikael Rostedt, Antti Luiro
LeadDesk

LeadDesk Q2'26 preview: Forbedret rentabilitet forventes trods faldende omsætning

Analyst Comment 13.08.2026, 07.07 by Frans-Mikael Rostedt, Antti Luiro
LeadDesk

Qt Group Q2'26: Markedet begynder at røre på sig

Research 07.08.2026, 06.30 by Antti Luiro, Atte Riikola
Qt Group

Qt Group Q2'26 - hurtig kommentar: Retningen forbedres hurtigere end forventet

Analyst Comment 06.08.2026, 08.06 by Antti Luiro, Atte Riikola
Qt Group

Qt Group Q2'26 preview: Indtjeningsvæksten fortsætter med at være midlertidig et stykke tid endnu

Analyst Comment 05.08.2026, 07.58 by Antti Luiro, Atte Riikola
Qt Group

Aiforia secured a 20 MEUR financing agreement with the EIB

Analyst Comment 03.08.2026, 08.19 by Antti Siltanen, Antti Luiro
Aiforia Technologies